← Back to Analyst Consensus 
CEVA Buy
CEVA INC
Current Price —
Implied Upside —
Analysts 16
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 1 reiterations from 1 firms
Next Earnings
Nov 9, 2026 (14 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Oct 19, 2026 | TD Cowen | maintain | Buy → Buy | — | 54% |
| Sep 14, 2026 | StoneX | upgrade | Hold → Buy | — | — |
| Aug 11, 2026 | TD Cowen | maintain | Buy → Buy | — | 54% |
| Aug 11, 2026 | Oppenheimer | maintain | Outperform → Outperform | — | 52% |
| Aug 11, 2026 | Rosenblatt | maintain | Buy → Buy | — | 55% |
| Aug 10, 2026 | Needham | maintain | Buy → Buy | — | 50% |
| Jul 16, 2026 | Benchmark | initiate | — → Hold | — | 54% |
| Jul 13, 2026 | TD Cowen | maintain | Buy → Buy | — | 54% |
| Jul 10, 2026 | Stifel | maintain | Buy → Buy | — | 53% |
| Jun 15, 2026 | Needham | initiate | — → Buy | — | 50% |
| May 12, 2026 | UBS | maintain | Buy → Buy | — | 54% |
| May 12, 2026 | Rosenblatt | maintain | Buy → Buy | — | 55% |
| May 12, 2026 | Oppenheimer | maintain | Outperform → Outperform | — | 52% |
| May 12, 2026 | TD Cowen | maintain | Buy → Buy | — | 54% |
| May 12, 2026 | JP Morgan | maintain | Neutral → Neutral | — | 54% |
| May 8, 2026 | JP Morgan | initiate | — → Neutral | — | 54% |
| May 4, 2026 | UBS | maintain | Buy → Buy | — | 54% |
| Mar 20, 2026 | TD Cowen | initiate | — → Buy | — | 54% |
| Mar 12, 2026 | Rosenblatt | maintain | Buy → Buy | — | 55% |
| Feb 25, 2026 | UBS | initiate | — → Buy | $27 | 54% |
| Feb 18, 2026 | Oppenheimer | reiterate | Outperform → Outperform | $30 | 52% |
| Feb 18, 2026 | Rosenblatt | maintain | Buy → Buy | $40 | 55% |
| Dec 1, 2025 | Loop Capital | initiate | — → Buy | $28 | 54% |
| Nov 12, 2025 | Barclays | maintain | Overweight → Overweight | $35 | 53% |
| Nov 11, 2025 | Rosenblatt | maintain | Buy → Buy | $40 | 55% |
| Aug 14, 2025 | Rosenblatt | maintain | Buy → Buy | $40 | 55% |
| May 9, 2025 | Oppenheimer | maintain | Outperform → Outperform | $33 | 52% |
| May 8, 2025 | Barclays | maintain | Overweight → Overweight | $30 | 53% |
| May 8, 2025 | Rosenblatt | maintain | Buy → Buy | $40 | 55% |
| Apr 23, 2025 | Rosenblatt | maintain | Buy → Buy | $45 | 55% |
| Feb 14, 2025 | Rosenblatt | maintain | Buy → Buy | $45 | 55% |
| Feb 14, 2025 | Barclays | maintain | Overweight → Overweight | $40 | 53% |
| Feb 11, 2025 | Rosenblatt | maintain | Buy → Buy | $35 | 55% |
| Dec 23, 2024 | Northland Capital Markets | maintain | Outperform → Outperform | $35 | 50% |
| Nov 8, 2024 | Rosenblatt | maintain | Buy → Buy | $35 | 55% |
| Nov 8, 2024 | Roth MKM | maintain | Buy → Buy | $40 | 52% |
| Oct 31, 2024 | Rosenblatt | maintain | Buy → Buy | $28 | 55% |
| Aug 8, 2024 | Oppenheimer | maintain | Outperform → Outperform | $33 | 52% |
| Aug 8, 2024 | Roth MKM | upgrade | Neutral → Buy | $25 | 52% |
| May 10, 2024 | Roth MKM | maintain | Neutral → Neutral | $20 | 52% |
| Feb 13, 2024 | Rosenblatt | reiterate | Buy → Buy | $28 | 55% |
| Dec 7, 2023 | Rosenblatt | reiterate | Buy → Buy | $28 | 55% |
| Aug 11, 2023 | Barclays | maintain | Overweight → Overweight | $29 | 53% |
| Aug 10, 2023 | Northland Capital Markets | maintain | Outperform → Outperform | $30 | 50% |
| Aug 10, 2023 | Roth MKM | downgrade | Buy → Neutral | $20 | 52% |
| Aug 10, 2023 | Rosenblatt | maintain | Buy → Buy | $35 | 55% |
| Aug 10, 2023 | Barclays | maintain | Overweight → Overweight | $29 | 53% |
| May 11, 2023 | Oppenheimer | maintain | Outperform → Outperform | $35 | 52% |
| May 11, 2023 | Roth MKM | maintain | — → Buy | $30 | 52% |
| May 11, 2023 | TD Cowen | maintain | — → Outperform | $30 | 54% |
Price Target Trend
May 13, 2026 Oct 26, 2026
EPS Estimates
0q —
+1y —
+1q —
0y —
Cross-Platform Signals
No cross-platform signals in the last 90 days